Ordinary Adjustment | Solactive China Biotech Index Family | Effective 11. July 2022
Solactive China Biotech Index:
In the ordinary rebalancing the following index composition was implemented:
| APELOA PHARMACEUTICAL CO-A | 1.8461 % |
| BEIJING TIANTAN BIOLOGICAL-A | 2.3178 % |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD | 0.7227 % |
| BETTA PHARMACEUTICALS CO L-A | 1.9841 % |
| BGI GENOMICS CO LTD-A | 2.353 % |
| CANSINO BIOLOGICS INC | 0.6963 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.1119 % |
| DAAN GENE CO LTD-A | 2.483 % |
| GAN & LEE PHARMACEUTICALS -A | 1.1977 % |
| GENSCRIPT BIOTECH CORP | 4.4339 % |
| HANSOH PHARMACEUTICAL GROUP CO | 2.2551 % |
| HUALAN BIOLOGICAL ENGINEER-A | 2.8982 % |
| HUBEI JUMPCAN PHARMACEUT-A | 1.3601 % |
| HUTCHISON CHINA MEDITECH-ADR | 2.3485 % |
| Hygeia Healthcare Holdings Co Ltd | 2.2211 % |
| INNOVENT BIOLOGICS INC | 6.7076 % |
| JIANGSU HENGRUI MEDICINE CO LTD CLASS A | 9.0 % |
| LIVZON PHARMACEUTICAL GROU-A | 2.0098 % |
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO LTD | 1.6081 % |
| REMEGEN CO LTD-H | 0.6737 % |
| SHANGHAI JUNSHI BIOSCIENCE | 4.1255 % |
| SHANGHAI RAAS BLOOD PRODUC-A | 2.2476 % |
| SHENZHEN KANGTAI BIOLOGICA-A | 2.9013 % |
| SIMCERE PHARMACEUTICAL GROUP | 0.6734 % |
| SINO BIOPHARMACEUTICAL LTD ORD | 6.3309 % |
| WALVAX BIOTECHNOLOGY CO-A | 9.0 % |
| WUXI APPTEC CO LTD-A | 9.0 % |
| WUXI BIOLOGICS CAYMAN INC | 9.0 % |
| ZAI LAB LTD | 3.5369 % |
| ZHEJIANG WOLWO BIO-PHARMAC-A | 1.9558 % |
Solactive China Biotech v2 Index:
In the ordinary rebalancing the following index composition was implemented:
| APELOA PHARMACEUTICAL CO-A | 1.8461 % |
| BEIJING TIANTAN BIOLOGICAL-A | 2.3178 % |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD | 0.7227 % |
| BETTA PHARMACEUTICALS CO L-A | 1.9841 % |
| BGI GENOMICS CO LTD-A | 2.353 % |
| CANSINO BIOLOGICS INC | 0.6963 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.1119 % |
| DAAN GENE CO LTD-A | 2.483 % |
| GAN & LEE PHARMACEUTICALS -A | 1.1977 % |
| GENSCRIPT BIOTECH CORP | 4.4339 % |
| HANSOH PHARMACEUTICAL GROUP CO | 2.2551 % |
| HUALAN BIOLOGICAL ENGINEER-A | 2.8982 % |
| HUBEI JUMPCAN PHARMACEUT-A | 1.3601 % |
| HUTCHISON CHINA MEDITECH-ADR | 2.3485 % |
| Hygeia Healthcare Holdings Co Ltd | 2.2211 % |
| INNOVENT BIOLOGICS INC | 6.7076 % |
| JIANGSU HENGRUI MEDICINE CO LTD CLASS A | 9.0 % |
| LIVZON PHARMACEUTICAL GROU-A | 2.0098 % |
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO LTD | 1.6081 % |
| REMEGEN CO LTD-H | 0.6737 % |
| SHANGHAI JUNSHI BIOSCIENCE | 4.1255 % |
| SHANGHAI RAAS BLOOD PRODUC-A | 2.2476 % |
| SHENZHEN KANGTAI BIOLOGICA-A | 2.9013 % |
| SIMCERE PHARMACEUTICAL GROUP | 0.6734 % |
| SINO BIOPHARMACEUTICAL LTD ORD | 6.3309 % |
| WALVAX BIOTECHNOLOGY CO-A | 9.0 % |
| WUXI APPTEC CO LTD-A | 9.0 % |
| WUXI BIOLOGICS CAYMAN INC | 9.0 % |
| ZAI LAB LTD | 3.5369 % |
| ZHEJIANG WOLWO BIO-PHARMAC-A | 1.9558 % |